57 related articles for article (PubMed ID: 22301450)
1. Differential treatment regimen-related effects of HU210 on CB(1) and D(2)-like receptor functionality in the rat basal ganglia.
Nguyen VH; Wang H; Verdurand M; Zavitsanou K
Pharmacology; 2012; 89(1-2):64-73. PubMed ID: 22301450
[TBL] [Abstract][Full Text] [Related]
2. Activation of spinal cannabinoid 1 receptors inhibits C-fibre driven hyperexcitable neuronal responses and increases [35S]GTPgammaS binding in the dorsal horn of the spinal cord of noninflamed and inflamed rats.
Drew LJ; Harris J; Millns PJ; Kendall DA; Chapman V
Eur J Neurosci; 2000 Jun; 12(6):2079-86. PubMed ID: 10886347
[TBL] [Abstract][Full Text] [Related]
3. Subchronic haloperidol increases CB(1) receptor binding and G protein coupling in discrete regions of the basal ganglia.
Andersson M; Terasmaa A; Fuxe K; Strömberg I
J Neurosci Res; 2005 Oct; 82(2):264-72. PubMed ID: 16175569
[TBL] [Abstract][Full Text] [Related]
4. β-arrestin2 regulates cannabinoid CB1 receptor signaling and adaptation in a central nervous system region-dependent manner.
Nguyen PT; Schmid CL; Raehal KM; Selley DE; Bohn LM; Sim-Selley LJ
Biol Psychiatry; 2012 Apr; 71(8):714-24. PubMed ID: 22264443
[TBL] [Abstract][Full Text] [Related]
5. HU210-induced downregulation in cannabinoid CB1 receptor binding strongly correlates with body weight loss in the adult rat.
Dalton VS; Wang H; Zavitsanou K
Neurochem Res; 2009 Jul; 34(7):1343-53. PubMed ID: 19169813
[TBL] [Abstract][Full Text] [Related]
6. Significance of cannabinoid CB1 receptors in improgan antinociception.
Gehani NC; Nalwalk JW; Razdan RK; Martin BR; Sun X; Wentland M; Abood ME; Hough LB
J Pain; 2007 Nov; 8(11):850-60. PubMed ID: 17644043
[TBL] [Abstract][Full Text] [Related]
7. Interactions between CB1 cannabinoid and mu opioid receptors mediating inhibition of neurotransmitter release in rat nucleus accumbens core.
Schoffelmeer AN; Hogenboom F; Wardeh G; De Vries TJ
Neuropharmacology; 2006 Sep; 51(4):773-81. PubMed ID: 16806307
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoid effects on CB1 receptor density in the adolescent brain: an autoradiographic study using the synthetic cannabinoid HU210.
Dalton VS; Zavitsanou K
Synapse; 2010 Nov; 64(11):845-54. PubMed ID: 20842718
[TBL] [Abstract][Full Text] [Related]
9. Differential treatment regimen-related effects of cannabinoids on D1 and D2 receptors in adolescent and adult rat brain.
Dalton VS; Zavitsanou K
J Chem Neuroanat; 2010 Dec; 40(4):272-80. PubMed ID: 20673846
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoids modulate ultrasound-induced aversive responses in rats.
Finn DP; Jhaveri MD; Beckett SR; Kendall DA; Marsden CA; Chapman V
Psychopharmacology (Berl); 2004 Feb; 172(1):41-51. PubMed ID: 14634713
[TBL] [Abstract][Full Text] [Related]
11. The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors.
Ottani A; Leone S; Sandrini M; Ferrari A; Bertolini A
Eur J Pharmacol; 2006 Feb; 531(1-3):280-1. PubMed ID: 16438952
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid CB(1) receptor activation stimulates neurite outgrowth and inhibits capsaicin-induced Ca(2+) influx in an in vitro model of diabetic neuropathy.
Zhang F; Challapalli SC; Smith PJ
Neuropharmacology; 2009 Aug; 57(2):88-96. PubMed ID: 19501110
[TBL] [Abstract][Full Text] [Related]
13. Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis.
Marcellino D; Carriba P; Filip M; Borgkvist A; Frankowska M; Bellido I; Tanganelli S; Müller CE; Fisone G; Lluis C; Agnati LF; Franco R; Fuxe K
Neuropharmacology; 2008 Apr; 54(5):815-23. PubMed ID: 18262573
[TBL] [Abstract][Full Text] [Related]
14. Detection of cannabinoid agonist evoked increase in BOLD contrast in rats using functional magnetic resonance imaging.
Shah YB; Prior MJ; Dixon AL; Morris PG; Marsden CA
Neuropharmacology; 2004 Mar; 46(3):379-87. PubMed ID: 14975693
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo pharmacology of synthetic olivetol- or resorcinol-derived cannabinoid receptor ligands.
Cascio MG; Bisogno T; Palazzo E; Thomas A; van der Stelt M; Brizzi A; de Novellis V; Marabese I; Ross R; van de Doelen T; Brizzi V; Pertwee R; Maione S; Di Marzo V
Br J Pharmacol; 2006 Oct; 149(4):431-40. PubMed ID: 16953186
[TBL] [Abstract][Full Text] [Related]
16. Release of arachidonic acid by 2-arachidonoyl glycerol and HU210 in PC12 cells; roles of Src, phospholipase C and cytosolic phospholipase A(2)alpha.
Nabemoto M; Mashimo M; Someya A; Nakamura H; Hirabayashi T; Fujino H; Kaneko M; Okuma Y; Saito T; Yamaguchi N; Murayama T
Eur J Pharmacol; 2008 Aug; 590(1-3):1-11. PubMed ID: 18539271
[TBL] [Abstract][Full Text] [Related]
17. Effects on turning of microinjections into basal ganglia of D(1) and D(2) dopamine receptors agonists and the cannabinoid CB(1) antagonist SR141716A in a rat Parkinson's model.
El-Banoua F; Caraballo I; Flores JA; Galan-Rodriguez B; Fernandez-Espejo E
Neurobiol Dis; 2004 Jul; 16(2):377-85. PubMed ID: 15193294
[TBL] [Abstract][Full Text] [Related]
18. The effects of cannabinoid drugs on abnormal involuntary movements in dyskinetic and non-dyskinetic 6-hydroxydopamine lesioned rats.
Walsh S; Gorman AM; Finn DP; Dowd E
Brain Res; 2010 Dec; 1363():40-8. PubMed ID: 20888328
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid inhibition of the capsaicin-induced calcium response in rat dorsal root ganglion neurones.
Millns PJ; Chapman V; Kendall DA
Br J Pharmacol; 2001 Mar; 132(5):969-71. PubMed ID: 11226126
[TBL] [Abstract][Full Text] [Related]
20. An optimized approach to study endocannabinoid signaling: evidence against constitutive activity of rat brain adenosine A1 and cannabinoid CB1 receptors.
Savinainen JR; Saario SM; Niemi R; Järvinen T; Laitinen JT
Br J Pharmacol; 2003 Dec; 140(8):1451-9. PubMed ID: 14623770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]